Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.73 USD | +1.76% | +3.59% | -48.05% |
Jun. 28 | NKFPharma's Unit Buys Yusimry's Rights for $40 Million | MT |
Jun. 27 | Coherus BioSciences to Sell Yusimry to Hong Kong King-Friend Industrial in $40 Million Cash Transaction | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.05% | 198M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus BioSciences, Inc. Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-10-2024 09